AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


American Journal of Public Health, Vol. 87, Issue 9 1554-1557, Copyright © 1997 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJPH
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ingster, L M
Right arrow Articles by Feinleib, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ingster, L M
Right arrow Articles by Feinleib, M
Could salicylates in food have contributed to the decline in cardiovascular disease mortality? A new hypothesis.

L M Ingster and M Feinleib

National Center for Health Statistics, Hyattsville, Md. 20782, USA.

OBJECTIVES: The prophylactic effect of aspirin (at 80 mg/day) for the prevention of cardiovascular disease mortality has long been recognized. This study examined whether other salicylates are present in comparable quantities in the US food supply. METHODS: To estimate the order of magnitude for salicylates in the food supply, annual production data for selected synthetic salicylates were analyzed. RESULTS: Production figures for 1960 indicate exposure to salicylates of 250 mg/day per person, or 95 mg/day per person excluding aspirin. Trend data indicate a rise in the production of salicylates over time, reaching 341 mg/day per person, or 126 mg/day per person excluding aspirin, in 1970. CONCLUSIONS: The US ingestion of salicylates with aspirinlike properties may have increased to the point that many susceptible individuals have received a beneficial effect that has contributed to the decline in cardiovascular disease mortality.


Related articles in AJPH:

Salicylate intake and cardiovascular disease.
F B Hu and W C Willett
AJPH 1998 88: 1124. [PDF]  



This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
J R Lawrence, R Peter, G J Baxter, J Robson, A B Graham, and J R Paterson
Urinary excretion of salicyluric and salicylic acids by non-vegetarians, vegetarians, and patients taking low dose aspirin
J. Clin. Pathol., September 1, 2003; 56(9): 651 - 653.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
S. Sans and A. Evans
Are cardiovascular disease trends driven by gadflies?
Int. J. Epidemiol., June 1, 2001; 30(3): 624 - 625.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Public Health Association